Trump Administration Launches Discount Drug Platform TrumpRx

The new website promises 'low cost prescription drugs,' but will not prescribe or sell drugs directly to the patient.

Feb. 5, 2026 at 7:15pm

Got story updates? Submit your updates here. ›

The Trump administration has announced that its discount drug platform, TrumpRx, will launch on Thursday, February 5th. The website is touted as a 'state of the art' platform for Americans to purchase low-cost prescription drugs. However, the site will not prescribe or sell drugs directly, but rather serve as a portal for patients to navigate to medication websites to purchase them.

Why it matters

The TrumpRx platform is the latest effort by the Trump administration to address the high cost of prescription drugs in the U.S., where patients can pay up to three times more than other developed countries for the same medications. While the administration has touted a 'most favored nation' pricing model, experts say the platform may only benefit a small number of people paying out-of-pocket, and offer little advantage for those with private insurance or Medicaid.

The details

The TrumpRx website will launch on February 5th at 7 p.m., with President Trump, CMS administrator Dr. Mehmet Oz, and Airbnb co-founder Joe Gebbia expected to unveil it. The site will not prescribe or sell drugs directly, but rather serve as a portal for patients to navigate to medication websites to purchase them. The administration has made deals with at least 16 manufacturers to offer discounted drugs on the platform, including medications like Januvia, Repatha, Wegovy, and Zepbound. However, pricing for the drugs will vary widely, with examples ranging from $16 per month for the blood thinner Plavix to $2,425 for a 12-week hepatitis C treatment.

  • The TrumpRx website will launch on Thursday, February 5, 2026 at 7 p.m.

The players

Donald Trump

The former President of the United States who is expected to unveil the TrumpRx website.

Dr. Mehmet Oz

The administrator of the Centers for Medicare and Medicaid Services who is expected to unveil the TrumpRx website.

Joe Gebbia

The co-founder of Airbnb who oversees the National Design Studio, which designs federal websites, and is expected to unveil the TrumpRx website.

Karoline Leavitt

The press secretary who described the TrumpRx website as a 'state of the art website for Americans consumers to purchase low cost prescription drugs.'

Rena Conti

An associate professor at the Boston University Questrom School of Business who stated that 'TrumpRx might support access and affordability for a very small number of people.'

Juliette Cubanski

The deputy director of the program on Medicare Policy at KFF who stated that 'There's no clear advantage for most people to use TrumpRx to purchase their medications.'

Got photos? Submit your photos here. ›

What they’re saying

“This historic announcement will save millions of Americans money. You won't want to miss it!”

— Karoline Leavitt, Press Secretary (X)

“TrumpRx might support access and affordability for a very small number of people.”

— Rena Conti, Associate Professor, Boston University Questrom School of Business (CNN)

“There's no clear advantage for most people to use TrumpRx to purchase their medications.”

— Juliette Cubanski, Deputy Director, Program on Medicare Policy at KFF (NBC News)

What’s next

The full list of available medications on the TrumpRx platform has not yet been released, but more details are expected to be announced during the launch event on February 5th.

The takeaway

While the Trump administration touts the TrumpRx platform as a way to provide low-cost prescription drugs to Americans, experts caution that it may only benefit a small subset of patients paying out-of-pocket, and offer little advantage for those with private insurance or Medicaid coverage.